Sodium–glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: a population-based cohort study - Top-Institutions - MDSpire

Sodium–glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: a population-based cohort study

  • By

  • Mi-Hyang Jung

  • Jung Sun Cho

  • So-Young Lee

  • Jong-Chan Youn

  • Young Choi

  • Woo-Baek Chung

  • Jungkuk Lee

  • Dongwoo Kang

  • Woojin Kwon

  • Tae-Seok Kim

  • Sang-Hyun Ihm

  • Hae Ok Jung

  • November 22, 2024

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Heart Failure
    • Genetic Cardiomyopathies

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Diabetes and Metabolism

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Genetics
    • Endocrinology

  • #4

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Heart Failure

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Genetic Heart Disease

Original Source(s)

Sodium–glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: a population-based cohort study

  • by Mi-Hyang Jung, Jung Sun Cho, So-Young Lee, Jong-Chan Youn, Young Choi, Woo-Baek Chung, Jungkuk Lee, Dongwoo Kang, Woojin Kwon, Tae-Seok Kim, Sang-Hyun Ihm, Hae Ok Jung

  • November 22, 2024

Related Content

Correction: Association between systemic immune-inflammation index(SII) and all-cause and cardiovascular mortality in heart failure patients: a single-center retrospective analysis

Transcatheter closure of PDA: how the pathway changed from classical fluoroscopy approach

Transcriptomic signatures and immune microenvironment of acute rejection after heart transplantation: an integrated bioinformatics analysis